{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:25:22Z","timestamp":1791944722866,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03974-w","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:02:10Z","timestamp":1748505730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disulfide bond-related gene signature development for bladder cancer prognosis prediction and immune microenvironment characterization"],"prefix":"10.1038","volume":"15","author":[{"given":"Hua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"1","key":"3974_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9(1), 58 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3974_CR2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A. et al. Advances in diagnosis and treatment of bladder cancer. Bmj 384, e076743 (2024).","journal-title":"Bmj"},{"issue":"1","key":"3974_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","volume":"75","author":"JI Warrick","year":"2019","unstructured":"Warrick, J. I. et al. Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants. Eur. Urol. 75(1), 18\u201322 (2019).","journal-title":"Eur. Urol."},{"issue":"2","key":"3974_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L. et al. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer. 21(2), 104\u2013121 (2021).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"3974_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell. Biol. 25(3), 404\u2013414 (2023).","journal-title":"Nat. Cell. Biol."},{"key":"3974_CR6","doi-asserted-by":"crossref","unstructured":"Jiang, Y. & Sun, M. SLC7A11: The achilles heel of tumor? Front. Immunol. 15, 1438807 (2024).","DOI":"10.3389\/fimmu.2024.1438807"},{"issue":"7","key":"3974_CR7","doi-asserted-by":"publisher","first-page":"e2408789","DOI":"10.1002\/advs.202408789","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Inhibition of endoplasmic reticulum stress cooperates with SLC7A11 to promote disulfidptosis and suppress tumor growth upon glucose limitation. Adv. Sci. (Weinh)  12(7), e2408789 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"3974_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12935-023-03204-1","volume":"24","author":"L Zhong","year":"2024","unstructured":"Zhong, L. et al. Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma. Cancer Cell. Int. 24(1), 2 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"3974_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41389-024-00535-0","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. Oncogenesis 13(1), 31 (2024).","journal-title":"Oncogenesis"},{"issue":"1","key":"3974_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13062-024-00544-4","volume":"19","author":"Z Kang","year":"2024","unstructured":"Kang, Z. et al. Disulfidptosis-related subtype and prognostic signature in prostate cancer. Biol. Direct 19(1), 97 (2024).","journal-title":"Biol. Direct"},{"issue":"1","key":"3974_CR11","doi-asserted-by":"publisher","first-page":"22220","DOI":"10.1038\/s41598-023-49750-6","volume":"13","author":"B Li","year":"2023","unstructured":"Li, B. et al. Analysis of long non-coding RNAs associated with disulfidptosis for prognostic signature and immunotherapy response in uterine corpus endometrial carcinoma. Sci. Rep. 13(1), 22220 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"3974_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12935-024-03374-6","volume":"24","author":"H Yao","year":"2024","unstructured":"Yao, H. et al. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma. Cancer Cell. Int. 24 (1), 183 (2024).","journal-title":"Cancer Cell. Int."},{"key":"3974_CR13","doi-asserted-by":"crossref","unstructured":"Jia, X. et al. Constructed risk prognosis model associated with Disulfidptosis LncRNAs in HCC. Int. J. Mol. Sci.  24(24) (2023).","DOI":"10.3390\/ijms242417626"},{"key":"3974_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2756-3_1","volume":"2584","author":"K Danielski","year":"2023","unstructured":"Danielski, K. Guidance on processing the 10x genomics single cell gene expression assay. Methods Mol. Biol. 2584, 1\u201328 (2023).","journal-title":"Methods Mol. Biol."},{"key":"3974_CR15","doi-asserted-by":"publisher","first-page":"e18911","DOI":"10.7717\/peerj.18911","volume":"13","author":"Z Zhou","year":"2025","unstructured":"Zhou, Z. et al. Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes. PeerJ 13, e18911 (2025).","journal-title":"PeerJ"},{"issue":"1","key":"3974_CR16","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1038\/s41598-025-92297-x","volume":"15","author":"S Guo","year":"2025","unstructured":"Guo, S. et al. Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma. Sci. Rep. 15 (1), 8130 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"3974_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","volume":"31","author":"J Fucikova","year":"2021","unstructured":"Fucikova, J. et al. Calreticulin and cancer. Cell. Res. 31(1), 5\u201316 (2021).","journal-title":"Cell. Res."},{"key":"3974_CR18","doi-asserted-by":"crossref","unstructured":"Oresta, B. et al. Mitochondrial metabolic reprogramming controls the induction of Immunogenic cell death and efficacy of chemotherapy in bladder cancer. Sci. Transl Med. 13(575) (2021).","DOI":"10.1126\/scitranslmed.aba6110"},{"key":"3974_CR19","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3389\/fimmu.2020.01685","volume":"11","author":"M Loustau","year":"2020","unstructured":"Loustau, M. et al. HLA-G Neo-Expression on tumors. Front. Immunol. 11, 1685 (2020).","journal-title":"Front. Immunol."},{"key":"3974_CR20","doi-asserted-by":"publisher","first-page":"1166680","DOI":"10.3389\/fimmu.2023.1166680","volume":"14","author":"T Li","year":"2023","unstructured":"Li, T. et al. New progresses on cell surface protein HSPA5\/BiP\/GRP78 in cancers and COVID-19. Front. Immunol. 14, 1166680 (2023).","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"3974_CR21","doi-asserted-by":"publisher","first-page":"133323","DOI":"10.1016\/j.ijbiomac.2024.133323","volume":"274","author":"J Qin","year":"2024","unstructured":"Qin, J. et al. Expression of transferrin Receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer. Int. J. Biol. Macromol. 274 (Pt 1), 133323 (2024).","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"3974_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40001-024-01688-9","volume":"29","author":"R Tang","year":"2024","unstructured":"Tang, R. et al. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer. Eur. J. Med. Res. 29(1), 112 (2024).","journal-title":"Eur. J. Med. Res."},{"key":"3974_CR23","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.2147\/IJGM.S329208","volume":"14","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Upregulation of THBS1 is related to immunity and chemotherapy resistance in gastric cancer. Int. J. Gen. Med. 14, 4945\u20134957 (2021).","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"3974_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12967-020-02310-2","volume":"18","author":"R Cai","year":"2020","unstructured":"Cai, R. et al. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation. J. Transl Med. 18(1), 139 (2020).","journal-title":"J. Transl Med."},{"issue":"5","key":"3974_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568009620666200228123754","volume":"20","author":"L Liu","year":"2020","unstructured":"Liu, L. & Li, X. A review of IGF1 signaling and IGF1-related long noncoding RNAs in chemoresistance of Cancer. Curr. Cancer Drug Targets 20(5), 325\u2013334 (2020).","journal-title":"Curr. Cancer Drug Targets"},{"key":"3974_CR26","doi-asserted-by":"publisher","first-page":"110074","DOI":"10.1016\/j.cellsig.2021.110074","volume":"86","author":"S Li","year":"2021","unstructured":"Li, S. et al. NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K\/AKT pathway. Cell. Signal. 86, 110074 (2021).","journal-title":"Cell. Signal."},{"key":"3974_CR27","doi-asserted-by":"crossref","unstructured":"Machado Brand\u00e3o-Costa, R. et al. Extracellular matrix derived from high metastatic human breast cancer triggers epithelial-mesenchymal transition in epithelial breast cancer cells through \u0391v\u03b23 integrin. Int. J. Mol. Sci., 21(8) (2020).","DOI":"10.3390\/ijms21082995"},{"key":"3974_CR28","doi-asserted-by":"publisher","first-page":"156908","DOI":"10.1016\/j.cyto.2025.156908","volume":"189","author":"Z Shi","year":"2025","unstructured":"Shi, Z. et al. The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapy. Cytokine 189, 156908 (2025).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03974-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:02:14Z","timestamp":1748505734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03974-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03974-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18826"}}